Tadalafil use is associated with a lower incidence of Type 2 diabetes in men with benign prostatic hyperplasia: A population-based cohort study.

Atsushi TakayamaSatomi YoshidaKoji Kawakami

Published in: Journal of internal medicine (2024)

The incidence of T2DM was lower in men with BPH treated with tadalafil than in those treated with alpha-blockers. Thus, tadalafil may be more beneficial than alpha-blockers in preventing T2DM.

Keyphrases

benign prostatic hyperplasia
lower urinary tract symptoms
risk factors
angiotensin converting enzyme
middle aged
glycemic control
adipose tissue
insulin resistance